Chemomab Therapeutics Ltd. CMMB
1.19 USD +0.05 (+4.39%)
Regular-session close
1.19 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
1.15 Day range 1.33
1.00 52-week range 2.83
- YTD
- -27.88%
- 1 year
- -51.03%
News
benzinga.com Chemomab Therapeutics Q3 EPS $(0.63) Misses $(0.12) Estimate Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.12) by 472.73 percent. This is a 96.88 percent decrease over…
globenewswire.com Chemomab Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update Proposed merger with Scipher Medicine with plans to assess nebokitug in a Phase 2 precision medicine trial in rheumatoid arthritis (RA) continues to advance, with closing expected in the first…
